| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board
|
|
|
2018
|
79 |
5 |
p. i
|
artikel
|
| 2 |
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions
|
Castinetti, Frédéric
|
|
2018
|
79 |
5 |
p. 591-595
|
artikel
|
| 3 |
Expert opinion on immunotherapy induced diabetes
|
Smati, Sarra
|
|
2018
|
79 |
5 |
p. 545-549
|
artikel
|
| 4 |
Expert opinion on pituitary complications in immunotherapy
|
Briet, Claire
|
|
2018
|
79 |
5 |
p. 562-568
|
artikel
|
| 5 |
Expert opinion on the metabolic complications of mTOR inhibitors
|
Bouillet, Benjamin
|
|
2018
|
79 |
5 |
p. 583-590
|
artikel
|
| 6 |
Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors
|
Buffier, Perrine
|
|
2018
|
79 |
5 |
p. 574-582
|
artikel
|
| 7 |
Expert opinion on thyroid complications in immunotherapy
|
Illouz, Frederic
|
|
2018
|
79 |
5 |
p. 555-561
|
artikel
|
| 8 |
Expert opinion on thyroid complications of new anti-cancer therapies: Tyrosine kinase inhibitors
|
Drui, Delphine
|
|
2018
|
79 |
5 |
p. 569-573
|
artikel
|
| 9 |
Expert opinions on adrenal complications in immunotherapy
|
Haissaguerre, M.
|
|
2018
|
79 |
5 |
p. 539-544
|
artikel
|
| 10 |
Expert opinions on endocrine toxicity induced by new anticancer therapies: Precautions to be taken in performing and interpreting hormonal assays under immunotherapy
|
Lahlou, Najiba
|
|
2018
|
79 |
5 |
p. 550-554
|
artikel
|
| 11 |
Introduction to expert opinion on endocrine complications of new anticancer therapies
|
Castinetti, Frederic
|
|
2018
|
79 |
5 |
p. 535-538
|
artikel
|
Tijdschrift beschrijving